Introduction of Department of Molecular Biology for Public Health in SCDC Ye Lu Shanghai Municipal Center for Disease Control & Prevention Shanghai Institute.

Slides:



Advertisements
Similar presentations
Perinatal Hepatitis B Prevention
Advertisements

Update on Cholangiocarcinoma: What we have learned from the International Hepatobiliary Neoplasia Biorepository Roon Chaiteerakij, MD Mayo Clinic, Rochester,
Hepatitis B: Epidemiology
Hallauer 06/20011 Outcome evaluation of an universal hepatitis B immunisation programme Johannes F. Hallauer M.D. Health Systems Research Charité, Humboldt.
Protein GP73 (GOLGI PROTEIN 73) A NEW NON-INVASIVE BIOMARKER FOR ASSESSING LIVER FIBROSIS AND RISK OF PROGRESSION TO HEPATOCELLULAR CARCINOMA N.K. Gatselis,
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
BIOC 401. Blood Sample To Detect Breast Cancer Cancer is actually a group of many related diseases that all have to do with cells. Cells are the very.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
 Primary liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality  Hepatocellular carcinomas (HCCs)
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
Hepatitis in a surgeon- problem oriented learning: Part I Paul Froom MD, MOccH Chief of Epidemiology Israel- National Institute of Occupational and Environmental.
Chronic Disease in Missouri: Progress and Challenges Shumei Yun, MD, PhD Public Health Epidemiologist and Team Leader Chronic Disease and Nutritional Epidemiology.
HIV and AIDS: Protecting Yourself, Protecting Others David Lee, Mollie Williams, and Andrew Frankart.
Course 17: Neglected Tropical Diseases & NCDs 9 th GA of IAPB Hyderabad; 19 th September 2012 NCDs & Eye Health Converging interests and opportunities.
Genomics Alexandra Hayes. Genomics is the study of all the genes in a person, as well as the interactions of those genes with each other and a person’s.
Eleni Galani Medical Oncologist
Driving the Transition to Individualized Cancer Treatment by Addressing Critical Questions 1 Do I need surgery? chemotherapy? radiation? INVASIVE BREAST.
BIOLOGIC MARKERS IN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE By: Dr Chavoshi.
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero,
Self-introduction of Zhihai Jiang Trainee in EHIB of CDPH Shanghai Municipal Center for Disease Control and Prevention Jan 13, 2011.
This is the most comprehensive compilation of epidemiological information on Hepatitis C Graciously provided by the University Hepatitis Center (last updated.
Research on HBV in SCDC Xi Zhang, Ye Lu Shanghai Municipal Center for Disease Control and Prevention May, 2008.
Screening Introduction to Primary Care:
5 Most Common Cancers. 1 in 2 men and 1 in 3 women in Australia will be diagnosed with cancer before the age of 85.
INTRODUCTION High incidence rate High incidence rate Do not grow in the laboratory Do not grow in the laboratory Discovered in 1964 Discovered in 1964.
Non-infectious Chronic Diseases Control & Prevention in Zhabei District Jane Xiong Zhabei District CDC, Shanghai, China Aug 29,2006.
A brief introduction to Research Methodology By Dr.Shaikh Shaffi Ahamed Ph.d., Asst. Professor Dept. of Family & Community Medicine.
Chronic Diseases. Cardiovascular Disease  Disease that affects the heart or blood vessels  Two types – hypertension and atherosclerosis  Behavioral.
PERIODIC MEDICAL EXAMINATION BY DR. ANGELA ESOIMEME MBBS, MPH, FWACGP.
Saudi Diploma in Family Medicine / 24 1 Dr. Zekeriya Aktürk Preventive Medicine and Periodic Health Examinations in Primary Care.
Dr K N Prasad Community Medicine
Patient Information - Viral Hepatitis B (HBV)
©Edited by Mingrui Zhang, CS Department, Winona State University, 2008 Identifying Lung Cancer Risks.
Understanding Cancer Developed by: Lewis J. Kleinsmith, Ph.D. Donna Kerrigan, M.S. Jeanne Kelly Brian Hollen.
Biobanks of Cerice Center for Gene Expression Research in Cancer Epidemiology Eiliv Lund, UiTø.
New Oslo PSC biobank.  Broad consent – covers all clinical and research biobanking  Integrated storage of clinical data and biological material  DNA,
Public Health Preventive Medicine and Epidemiology Prof. Ashry Gad Mohammed MB, ChB. MPH, Dr P.H Prof. of Epidemiology College of Medicine King Saud University.
Effects of Smoking on Health Prepared by Amr Said Dahroug.
LEADING CAUSES OF DEATH Causes of Death Lifestyle (%) Environment (%) Heredity (%) 1. Cardiovascular Cardiovascular Diseases CancerCancer
Copyright © 2008 Delmar Learning. All rights reserved. Unit 6 Classification of Disease.
Unit 2 – Public Health Epidemiology Chapter 4 – Epidemiology: The Basic Science of Public Health.
Community based integrated intervention for prevention and management of Chronic Obstructive Pulmonary Disease in Guangdong, China: cluster randomised.
PZP: A novel biomarker for early Alzheimer’s disease ? Diana A.T. Nijholt Department of Neurology Laboratory for Clinical and Cancer Proteomics
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
Dr Godfrey Grech University of Malta
Understanding Cancer and Related Topics
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Organization of statistical research. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and.
Epidemiology 242: Cancer Epidemiology Zuo-Feng Zhang, MD, PhD Fall Quarter, 2009.
Dr. Jeyaparvathi Somasundaram
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2.
Evaluation of Hepatitis B surveillance system in Armenia, 2014 AUTHORS Karine Gevorgyan Lusine Paronyan Shushan Sargsyan Artavazd Vanyan NCDC, Armenia.
Parallel and Overlapping Prevalence of Hepatitis B and C Viruses in Apparently Healthy Individuals in a Northern Nigerian Population Pennap, GRI and Chuga,
Department of Preventive Medicine Faculty of Public Health University of Debrecen General Practitioners’ Morbidity Sentinel Stations Program (GPMSSP) to.
INTRODUCTION & OBJECTIVES Introduction: The carcinogenesis of hepatocellular carcinoma (HCC) is a multifactorial, multistep and complex process. Its prognosis.
Understanding Epidemiology Introduction to Epidemiology and Epidemiological Concepts.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
New research areas in personalised medicines
Ch Epidemiology Microbiology.
The Value of Measurement of Circulating Tumor Cells in Hepatocellular Carcinoma Nashwa Sheble, Gehan Hamdy, Moones A Obada, Gamal Y Abouria, Fatma Khalaf.
prevention and control of non communicable diseases in Iraq
Presented By: Sally Saad Mandour Esawy
HEPATOCELLULAR CARCINOMA (HCC) at
HBV Infection: Some Sobering Facts
Evaluation of the Patient With HCV Infection
HEPATITIS C BY MBBSPPT.COM
Six W’s of Genetic Testing
Recent Incidences and Trends of the Top Cancers in Northeast Tennessee Appalachian Region Adekunle Oke1, Sylvester Orimaye2, Ndukwe Kalu1, Dr. Faustine.
Presentation transcript:

Introduction of Department of Molecular Biology for Public Health in SCDC Ye Lu Shanghai Municipal Center for Disease Control & Prevention Shanghai Institute of Prevention Medicine April,2008

Laboratory Building Department of Molecular Biology For Public Health (DMB)

Genomic Research Bio-bank Proteomic Research Bio-informatics Construction of DMB Bio-bank: collection, analysis and management of bio-samples Genomic research: SNP analysis of chronic diseases Proteomic research: differential proteomic research of infectious diseases and carcinoma Bio-informatics: research data analysis

Main Tasks of DMB Provide technical platform Cooperate on research projects

Research Projects Proteomic Research of Lung Cancer Proteomic Research of Liver fibrosis Proteomic Research of MDR-TB SNP analysis of COPD Early diagnosis of Breast Cancer Hypertension, Shock & Other Cardiovascular Diseases in Senior population

Objective Find serum biomarkers for early diagnosis of lung cancer. Explain the mechanism of the biomarkers, together with the relationship of smoking. Proteomic Research of Lung Cancer

Population Healthy Patients with shadow in lung Patients with nub in lung Patients with lung cancer

Technology: SELDI-TOF-MS

Methods Analyze the proteomic difference between healthy serum and lung cancer patient serum. Screen the difference among patients with shadow/nub in lung for early diagnosis of lung cancer. Analyze the relationship of the difference and the exposure to smoking.

Progression from HBV infection to cancer Exposure to HBV No infection Chronic infection Cirrhosis Asymptomatic carriers Slowly Progressive HCC ?%?% ?%?% 10% Years Infection Acute infection (HBV clearance) 90% Death ~25% Proteomic Research of Liver fibrosis Liver fibrosis is the middle stage in the course of chronic HBV infection.

Objective Find plasma biomarkers for early diagnosis of liver fibrosis Explain the mechanism of liver fibrosis

Population For screening: patients with different stages of liver fibrosis,but the same grade of liver inflammation For validation: patients with different stages of liver fibrosis and different grades of liver inflammation

Four stages of fibrosis (A ~ B:S1 ~ S4) Four grades of inflammation (A ~ B:G1 ~ G4)

Grade of Inflammation Stage of fibrosis G1G2G3G4 S1G1S1G2S1G3S1G4S1 S2G1S2G2S2G3S2G4S2 S3G1S3G2S3G3S3G4S3 S4G1S4G2S4G3S4G4S4 Screening Population Validation Population

Technology: 2D-DIGE

Methods Analyze the proteomic difference among various stages of liver fibrosis patients. Validate the difference in a large scale of clinical samples. Combine the proteomic difference with other 17 clinical tests for early diagnosis of liver fibrosis.

Proteomic Research of MDR-TB

Objective Find new antibody against MDR-TB in the serum of TB patients. Identify the corresponding antigen in TB strain. Find new method for early diagnosis of MDR- TB.

Technology: 2D-LC based SERPA

SNP analysis of COPD patients Air-pollution is one of the main causes of COPD. Molecular Mechanism SNP of related enzyme? Working Hypothesis Air-pollution DNA damage COPD DNA repair system ×

Collect clinical samples and healthy volunteers from Tai Yuan, San Xi Province, China. Analyze the SNP of DNA repair enzyme genes(ERCC2/XPD, XPA and XPG). Analyze the relationship among environmental exposure, occupation experience, gene SNP and clinical symptom of COPD.

Breast Cancer Have 8,000 women a mammogram test and an epidemiology survey. Follow up the incidence of breast cancer among the population. TO  Evaluate the effect of mammogram on the early diagnosis of breast cancer.  Analysis the risk facts of breast cancer. A mammogram is an x-ray of the breast, which may find tumors that are too small to feel.

Hypertension, Stroke & Other Cardiovascular Diseases Have 150,000 senior a medical check-up. Keep the results of the examination, and do an epidemiology survey. Collect bio-samples of plasma, serum and whole blood. Follow the incidence of various diseases among the population.  Get general health information  Give advice on healthcare TO

Bio-bank We are mostly interesting in Criteria of sample selection SOP for sample collection & storage Maintenance & management of bio-bank

Data analysis Associating Classifying Modeling & Simulating Predicting & Testing

Thank you!